PLCOm2012 Models Have High Sensitivity for Lung Cancer
TUESDAY, Oct. 10, 2023 -- Two versions of the PLCOm2012 risk ‐prediction model (based on the 2012 Prostate, Lung, Colorectal, and Ovarian [PLCO] Cancer Screening Trial), with and without a predictor for race, have high sensitivities for lung...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Lung Cancer | Ovarian Cancer | Ovaries | Pharmaceuticals